ROIV
Roivant Sciences Ltd. · Healthcare
Pres, Immunovant CEO Eric Venker sold $5.9M of Roivant Sciences Ltd.
Sold$5,918,000
$29.59Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Thu, Apr 23 open, $29.25
- −2.3%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jun 5 close.
Traded Mon, Apr 20. Filed Wed, Apr 22, 6:27 PM ET, after the close. Returns use the Apr 23 open and the Jun 5 close. Not investment advice.